01 Excimer Lamps Are Creating Competition Within Targeted Phototherapy Demand for targeted phototherapy is encouraging the use of 308 nm excimer lamps alongside conventional excimer lasers, particularly where clinics seek alternative device formats. A systematic review of six studies covering 411 patients and 764 lesions found no significant difference in ≥50% or ≥75% repigmentation between excimer lamps and excimer lasers for vitiligo. This comparable clinical performance is broadening device choices within targeted phototherapy.
02 Portable and Handheld Delivery Is Expanding Targeted Treatment Models The dermatology excimer laser market analysis shows that demand for localized treatment is supporting smaller and more focused phototherapy devices that can target individual lesions without exposing unaffected skin. Recent clinical research comparing 308 nm LED and excimer lamp treatment included 174 patients and 269 vitiligo patches, showing similar efficacy after 16 sessions, which indicates increasing interest in compact targeted light-delivery technologies. This shift can expand targeted phototherapy into more flexible treatment settings and support treatment of localized lesions.
01 Adoption of Excimer Laser Treatment in Specialty Clinics and Rising Preference for Non-Invasive Dermatological Treatments Drive Market Greater adoption of excimer laser treatment in specialty clinics increases demand for dermatology excimer laser systems as more providers add targeted phototherapy to their treatment offerings. Dermatology clinics, for example, can use excimer lasers for localized psoriasis and vitiligo lesions where focused treatment is required. This wider clinical adoption encourages equipment procurement and supports demand for excimer laser systems.Rising preference for non-invasive dermatological treatments increases demand for excimer laser therapy as patients and clinicians seek localized treatment options without surgical intervention. Patients with localized vitiligo or psoriasis, for example, can receive targeted laser treatment while limiting exposure to unaffected skin. This preference expands the patient base for non-invasive phototherapy and supports demand for dermatology excimer laser equipment.
01 Shortage of Skilled Dermatologists and Laser Specialists and Risk of Skin Irritation and Treatment-Related Adverse Effects Restrain Market Expansion Shortage of skilled dermatologists and laser specialists can limit the availability of professionals capable of operating excimer laser systems and selecting appropriate treatment protocols. Limited specialist availability can restrict treatment capacity, particularly in areas with fewer advanced dermatology facilities. Consequently, workforce shortages can slow adoption and constrain market expansion.Risk of skin irritation and treatment-related adverse effects can create concerns among patients undergoing excimer laser therapy, particularly when treatment intensity or exposure is not appropriately managed. These concerns can reduce patient acceptance and encourage healthcare providers to use alternative treatment options in some cases. As a result, safety concerns can slow treatment adoption and limit market growth.
01 Dermatology Excimer Lasers for Pediatric Skin Disorders and Dermatology Excimer Lasers for Scalp and Hair-Related Conditions Offers Growth Opportunities Pediatric dermatology clinics and specialized healthcare providers are key customers for excimer laser solutions designed for localized skin disorders in children. Companies such as XTRAC can expand revenue through pediatric treatment platforms, specialized clinical protocols, and equipment supply agreements with dermatology centers.Dermatology clinics, hair restoration centers, and patients with localized scalp conditions are key customers for excimer laser applications targeting selected inflammatory and pigment-related scalp disorders. Companies such as Alma Lasers can generate revenue through specialized laser platforms, treatment accessories, and partnerships with dermatology and aesthetic clinics, contributing to dermatology excimer laser market growth.
01 High Cost of Excimer Laser Equipment and Maintenance and Competition from Alternative Phototherapy and Topical Treatments Hinder Growth Excimer laser systems require substantial capital investment along with specialized maintenance, calibration, and replacement components, increasing the financial burden for dermatology clinics. These costs can make adoption difficult for smaller practices and limit the expansion of excimer laser treatment capacity beyond well-funded hospitals and specialty centers.Dermatologists can choose among narrowband UVB, topical therapies, systemic medicines, and other phototherapy approaches depending on the condition and patient profile. The availability of these alternatives can reduce demand for excimer laser treatments and make it more difficult for equipment manufacturers to expand adoption across diverse dermatology settings.
April 2026 Alma Lasers expanded its dermatology portfolio through the launch of next-generation laser-based skin treatment solutions, reinforcing its presence in advanced dermatology laser technologies for pigmentary and inflammatory skin disorders.
January 2026 STRATA Skin Sciences launched XTRAC® Momentum 2.0, introducing enhanced treatment software, improved workflow automation, and upgraded user interface features to strengthen its dermatology excimer laser portfolio.
July 2025 STRATA Skin Sciences expanded the commercialization of its XTRAC® Momentum 1.0 excimer laser system by increasing installations across dermatology clinics, enhancing treatment workflow and patient throughput for inflammatory skin diseases.
May 2025 Ra Medical Systems announced the commercial expansion of its Pharos® Excimer Laser platform for dermatology, strengthening its portfolio for the treatment of psoriasis, vitiligo, atopic dermatitis, and other chronic skin disorders.